Flags theoretical pathologic angiogenesis potential: PMC12446177 Evidence Summary Preclinical: IBD/colitis models: High remission rates, restored mucosal architecture, improved barrier function Tendon repair: Accelerated healing, improved tensile strength, reduced fibrosis Neurovascular: Sciatic nerve protection, enhanced blood vessel growth in nerve tissue Human data (emerging): Interstitial cystitis pilot (2024, n=12): 10/12 complete resolution, 2/12 at 80% improvement IV safety study (2025, n=2): no adverse effects on cardiac, hepatic, renal, or glucose biomarkers Knee pain retrospective (2021, n=17): 91.6% reported significant improvement No large-scale controlled trials published Safety: No immunosuppression or hormonal disruption in available data 2025 systematic review (HSS Journal): recommends caution due to limited high-quality clinical evidence 2025 narrative review: flags theoretical pathologic angiogenesis risk Stable in gastric acid (oral administration viable) No observed toxicity at therapeutic doses in published reports Foundational Reviews Sikiric P, Seiwerth S, et al
Both peptides are widely used in high-performance serums, anti-aging creams, scalp formulations and advanced cosmetic applications designed to support the appearance of youthful, radiant skin
See individual product pages for full intended-use details
Patients on Rybelsus combined with sulphonylureas or insulin should be advised to carry glucose tablets or a fast-acting carbohydrate source at all times and ensure family members or colleagues know how to recognise and respond to hypoglycaemia
To enhance the scientific rigor and translational potential of Wutou Decoction research, future studies should employ HDAC activity assay kits to measure the direct inhibitory effects of Wutou Decoction and its metabolites on HDAC1/7
